We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bionex Inv. | LSE:BNX | London | Ordinary Share | GB0032279258 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.29 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/12/2004 10:54 | Anyone else following this one? Based on last year's timings (not guaranteed to be repeated) the results are likely to be out next week. Where is this going? Wind-up, carry on as is, new strategy or reverse takeover? | topvest | |
25/11/2004 12:28 | Just to get the thread moving....tick up this morning. (A BNX holder) Cheers 1-4 | one for the money | |
25/10/2004 21:38 | The Vandyk family continue to raise their stake. Why? Is this a bargain? Two options - liquidation or a reverse takeover. What's the view? | topvest | |
24/10/2004 11:25 | All very quiet on this BB. Results probably 6-8 weeks off. Can see some excitement on these before Christmas, maybe triggered by a change in strategy or a reverse takeover. Any views? | topvest | |
12/10/2004 21:55 | Susan Vandyk tops-up again! | topvest | |
14/9/2004 22:46 | Well I hope Bionex do better than Bioprojects (Jim Slater) which is getting nowhere. The spread on BNX is terrible. | saturn5 | |
14/9/2004 14:42 | Is something going on behind the scenes on this one? It is a quite attractive cash shell at the moment, with a few investments thrown in. Still think that Edward Vandyk wouldn't have bought a shedload if there wasn't a plan for this company. | topvest | |
14/9/2004 09:33 | don't know what has prompted this. Still spread makes it uneconomical. same old problem. they need to consolidate the shares to get the spread down. | russianlinesman | |
14/9/2004 09:24 | 1.5/2.0. Excuse me!! | mjcrockett | |
16/8/2004 16:14 | This share purchase is a buy signal imo. Who owned the shares in Newbourne was a bit of a mystery. Newbourne funded Bionex by £500k pre-IPO at 3p. They have therefore crystallized a fairly heavy loss as they have sold out at 1.25p. Edward Vandyk (and his wife) seems to me to have got things about right - he sold a large proportion of his 5.2m shares shortly after the company's IPO and has now bought a much more sizeable stake at well below net asset value. The company is a much more attractive proposition now than it was a year ago (i.e. the CEO has left and they have liquidated most or all of their investment in Ark). The facts - this company c.£3m of liquid assets and minimal running costs. It is quite an attractive vehicle and that is why the Vandyks have started building a sizeable stake. I've added to my holding following this news. Bit of a gamble, but I think Edward Vandyk may have got some interesting ideas for this shell. | topvest | |
15/8/2004 10:05 | Bionex was spun out of Mountcashel and they still share same premises and run very closely together. The fact that S. V. has purchased these shares should be good news, although do not know who owned Newbourne. | bcf200 | |
14/8/2004 10:34 | Susan Vandyk is the wife of Edward Vandyk, CEO of Abingdon Capital. Abingdon Capital is an integrated financial services company offering corporate finance, corporate stockbroking, private equity and hedge fund management services. Its wholly-owned subsidiary, Corporate Synergy, is an advisory and institutional stockbroker that focuses on small companies. The company also owns about 25% of Mountcashel, a hedge fund management company. | busterdog2 | |
13/8/2004 16:27 | Fur, I assume you are referring to Susan Vandyk who now has a notifiable interest in 19,916,667 Ordinary shares, representing 12.61% of the Company's issued share capital. I don't know who she is, but she bought 6 million shares a few days ago, so she is certainly showing interest in the company. The 16.6m sold earlier at 1.25p was obviously the Newbourne Plc shares - it would seem that most, but not all, of these shares have gone to Ms Vandyk. MJ | mjcrockett | |
13/8/2004 14:56 | Who is this bird? | fur | |
13/8/2004 12:40 | nice big trade | fur | |
05/8/2004 07:02 | Twix, I am thinking about buying - just making sure they don't get any cheaper first. MJ | mjcrockett | |
04/8/2004 18:57 | buying on any set back guys Have you been in and bought yet or having second thoughts? If so why? Thanks | twix386 | |
30/6/2004 13:35 | 1.5m rollover? Why did they bother - not expecting anything here soon are we? | godolphin | |
15/6/2004 22:22 | Dang , just read the new's and had my idea's in mind , get to the bb and your all thinking exactly the same , guess we will be fighting over those 0.9p share's , cya in month or so ... .lol | blackbear | |
15/6/2004 15:17 | yes guys, looks ok for me, i will also be buying on any set back. but as stated the cash held will probably underpin the price. definately one to keep an eye on. regards james. | james111 | |
15/6/2004 13:50 | Agreed Simon, I was expecting a slightly higher NAV. I hope you are right about the price drifting back and if it does, I will certainly buy. However, with so much of the assets in cash the price may stay higher. Do you know if Bionex are in play for a takeover - it could be a route to easy money for a company in urgent need of cash. Durlacher did something like this a year or so back. MJ | mjcrockett | |
15/6/2004 13:29 | Results just out. Looks like £500k invested in the Mountcashel Hedge Fund that is linked to Abingdon Capital. NAV only 2.3p, so looking a tad pricey after the rise today imho. Looks interesting if it drops back to 1p at some point though. Results were disappointing - another investment w/d and a reasonably sizeable tax liability. Admin expenses are probably higher due to compensation to the CE0 in the period. | simonevans | |
15/6/2004 13:29 | Encouraging results today. As per the RNS. | lizzie ii |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions